Acutaas Chemicals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹53.64₹43.51₹19.81₹11.67₹22.86
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹53.42₹43.37₹19.81₹11.66₹22.86
₹201.97₹201.97₹159.97₹182.75₹163.01
₹194.52₹163.59₹122.99₹194.54₹169.26
—₹35.69₹14.46₹33.94₹17.98
−₹4.37−₹4.37−₹9.32−₹42.08−₹8.47
—₹1.50₹1.50₹2.96₹3.00
8.28.28.23.73.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACUTAAS₹3,148.30

Acutaas Chemicals Ltd.

· Pharma & Health
₹ CrorePeersANURASAETHERBLUEJETCAPLIPOINTCONCORDBIOEMCUREJBCHEPHARMERISMcap ₹25,776 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS22.8611.6719.8143.5153.64
Diluted EPS22.8611.6619.8143.3753.42
Book Value per Share163.01182.75159.97201.97201.97
Revenue per Share169.26194.54122.99163.59194.52
Cash Flow per Share17.9833.9414.4635.69—
Free Cash Flow per Share-8.47-42.08-9.32-4.37-4.37
Dividends per Share3.002.961.501.50—
Shares Outstanding (cr)3.63.78.28.28.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.